Dorr J - Search Results

1

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.

Aktas O, Waiczies S, Smorodchenko A, Dorr J, Seeger B, Prozorovski T, Sallach S, Endres M, Brocke S, Nitsch R, Zipp F. Aktas O, et al. Among authors: dorr j. J Exp Med. 2003 Mar 17;197(6):725-33. doi: 10.1084/jem.20021425. Epub 2003 Mar 10. J Exp Med. 2003. PMID: 12629065 Free PMC article.

2

Induction of TRAIL-mediated glioma cell death by human T cells.

Dörr J, Waiczies S, Wendling U, Seeger B, Zipp F. Dörr J, et al. J Neuroimmunol. 2002 Jan;122(1-2):117-24. doi: 10.1016/s0165-5728(01)00450-7. J Neuroimmunol. 2002. PMID: 11777550

3

Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain.

Dörr J, Bechmann I, Waiczies S, Aktas O, Walczak H, Krammer PH, Nitsch R, Zipp F. Dörr J, et al. J Neurosci. 2002 Feb 15;22(4):RC209. doi: 10.1523/JNEUROSCI.22-04-j0001.2002. J Neurosci. 2002. PMID: 11844843 Free PMC article.

4

Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients.

Infante-Duarte C, Weber A, Krätzschmar J, Prozorovski T, Pikol S, Hamann I, Bellmann-Strobl J, Aktas O, Dörr J, Wuerfel J, Stürzebecher CS, Zipp F. Infante-Duarte C, et al. Among authors: dorr j. FASEB J. 2005 Nov;19(13):1902-4. doi: 10.1096/fj.05-3832fje. Epub 2005 Sep 6. FASEB J. 2005. PMID: 16144955

5

Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis.

Paul F, Waiczies S, Wuerfel J, Bellmann-Strobl J, Dörr J, Waiczies H, Haertle M, Wernecke KD, Volk HD, Aktas O, Zipp F. Paul F, et al. Among authors: dorr j. PLoS One. 2008 Apr 9;3(4):e1928. doi: 10.1371/journal.pone.0001928. PLoS One. 2008. PMID: 18398457 Free PMC article. Clinical Trial.

6

Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.

Vogt J, Paul F, Aktas O, Müller-Wielsch K, Dörr J, Dörr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F. Vogt J, et al. Among authors: dorr j, dorr s. Ann Neurol. 2009 Sep;66(3):310-22. doi: 10.1002/ana.21719. Ann Neurol. 2009. PMID: 19798635

7

Tumor-necrosis-factor-related apoptosis-inducing-ligand (TRAIL)-mediated death of neurons in living human brain tissue is inhibited by flupirtine-maleate.

Dörr J, Roth K, Zurbuchen U, Deisz R, Bechmann I, Lehmann TN, Meier S, Nitsch R, Zipp F. Dörr J, et al. J Neuroimmunol. 2005 Oct;167(1-2):204-9. doi: 10.1016/j.jneuroim.2005.06.027. J Neuroimmunol. 2005. PMID: 16043230

8

Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells.

Wendling U, Walczak H, Dörr J, Jaboci C, Weller M, Krammer PH, Zipp F. Wendling U, et al. Among authors: dorr j. Cell Death Differ. 2000 Jul;7(7):637-44. doi: 10.1038/sj.cdd.4400692. Cell Death Differ. 2000. PMID: 10889508

9

Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.

Chanvillard C, Millward JM, Lozano M, Hamann I, Paul F, Zipp F, Dörr J, Infante-Duarte C. Chanvillard C, et al. Among authors: dorr j. PLoS One. 2012;7(6):e39625. doi: 10.1371/journal.pone.0039625. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768101 Free PMC article. Clinical Trial.

10

Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis.

Paul F, Dörr J, Würfel J, Vogel HP, Zipp F. Paul F, et al. Among authors: dorr j. BMJ Case Rep. 2009;2009:bcr06.2009.2004. doi: 10.1136/bcr.06.2009.2004. Epub 2009 Jul 7. BMJ Case Rep. 2009. PMID: 21734913 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters